北美兽用疫苗市场预测至 2028 年 - COVID-19 影响和按疫苗类型(牲畜疫苗 [牛疫苗和小型反刍动物疫苗]、伴侣动物疫苗 [猫疫苗、犬疫苗等] 等)和技术进行的区域分析(减毒活疫苗、灭活疫苗、类毒素疫苗、重组疫苗、结合疫苗等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 114    |    Report Code: TIPRE00027168    |    Category: Life Sciences

North America Veterinary Vaccines Market

市场介绍

北美兽用疫苗市场已细分为美国、加拿大和墨西哥。 2021年,美国在北美兽用疫苗市场中占据最大份额。畜牧集团为消费者提供不同的产品和服务,包括肉、奶、蛋、纤维和役力。牲畜、同情动物和其他动物之间的病毒感染是该国动物健康的一个重要方面。感染动物的病毒传播速度更快。因此,对动物进行此类病毒的免疫对于该国的动物保健至关重要。新冠肺炎疫情的爆发引发了动物的新冠疫苗接种。例如,2021 年 3 月,圣地亚哥动物园的猩猩和倭黑猩猩接种了冠状病毒疫苗。此外,该国的监管机构在控制动物和人类之间的感染传播方面制定了非常严格的政策。作为此类政策的一部分,这些机构采取了各种策略。例如,2021 年 6 月,美国在狂犬病虚假记录增多后禁止从 113 个国家进口狗。此外,2020年,美国疾控中心发现超过450只美国进口狗带有伪造或欺诈性狂犬病证书,估计与前几年相比增加了约52%。作为宠物和家畜日常保健计划的一部分,宠物疫苗接种是强制性的。动物国家的所有者对疫苗接种的认识显着提高,病毒感染的流行率不断上升,以及知名市场参与者的存在,预计将在预测年内促进兽用疫苗市场的增长.

在COVID-19的情况下,北美,尤其是美国,受到的影响很大。动物中已记录了 COVID-19 的发病率。此外,还存在伴侣动物通过人类同伴感染的情况。根据 CDC 的说法,动物已感染 SARS-CoV-2,世界各地均有记录。这些动物中的大多数是在与感染了 COVID-19 的主人、看护者和其他与动物有密切接触的人接触后被感染的。受感染的动物包括伴侣动物(包括宠物猫、狗、雪貂)、动物园和保护区的动物(不同类型的大型猫科动物、水獭、非人类灵长类动物、熊狸、长鼻浣熊、渔猫和鬣狗),以及水貂养殖场的水貂。作为预防措施,多个组织为动物接种 COVID-19 感染疫苗。例如,2021 年 10 月,辛辛那提动物园为约 80 只动物接种了两剂专为兽医使用的 COVID-19 疫苗,以预防 COVID-19。 COVID-19 大流行严重影响了该地区的动物健康。兽用疫苗市场的区域参与者积极参与生产和产品创新。此外,它还为市场参与者提供潜在的商机,对兽用疫苗市场产生积极影响。地方政府正在提供支持,以加强该地区的动物健康相关业务。

市场概况和动态

北美兽用疫苗市场预计将从2021年的37.2185亿美元增长到2028年的5884.41百万美元;预计 2021 年至 2028 年复合年增长率为 6.8%。兽医护理业务正在经历重大变革。该地区各国都青睐使用简单且有益于医疗保健的复杂疗法和补充剂。预计该地区的国家将成为兽医医疗保健扩张的最大贡献者之一。宠物拥有率的不断上升、人们可支配收入的增加以及对宠物健康的认识不断增强,这些因素可能会推动未来市场的增长。此外,各国动物福利的改善以及动物疫苗和营养补充剂生产规则的实施将推动未来几年新兴国家市场的增长。动物保健企业的业务方式发生了变化,从药品发展到预防,再到提高生产力,现在发展到动物的全面保健。预计这将增加潜在市场和几个国家对兽用疫苗的采用,预计将在预测期内为北美市场的增长创造利润丰厚的机会。

< strong>主要细分市场

从疫苗类型来看,牲畜疫苗占据了北美兽医市场的最大份额2020年疫苗市场。从技术角度来看,减毒活疫苗在2020年北美兽用疫苗市场中占有较大的市场份额。

主要来源和上市公司

准备本北美兽用疫苗市场报告时提到的一些主要一手和二手来源包括公司网站、年报、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有BIOVAC;勃林格殷格翰国际有限公司;塞瓦;埃兰科;海普拉;默克公司;纽根公司;维克;和 Zoetis Inc. 等

购买报告的理由

  • 了解北美兽用疫苗市场格局并确定最有可能保证丰厚回报的细分市场< /span>
  • 了解北美兽用疫苗市场不断变化的竞争格局,保持领先地位
  • 高效规划并购和并购通过确定最有希望销售的细分市场,在北美兽用疫苗市场开展合作
  • 通过对各种细分市场表现的敏锐和全面的分析,帮助做出明智的业务决策北美兽用疫苗市场
  • 获取北美地区2021-2028年各细分市场的市场收入预测

北美兽用疫苗市场细分

北美兽用疫苗市场 - 按疫苗类型

  • 牲畜疫苗
    • 牛疫苗
    • 小型反刍动物疫苗
  • 伴侣动物疫苗
    • 猫疫苗
    • 犬疫苗
    • 其他
  • 其他

北美兽用疫苗市场 - 作者:

技术

  • 减毒活疫苗
  • 灭活疫苗
  • 类毒素疫苗
  • 重组疫苗
  • < span>结合疫苗
  • 其他

北美兽用疫苗市场 - 作者国家/地区

  • 美国
  • 加拿大
  • 墨西哥

北美兽用疫苗市场 - 公司简介

  • BIOVAC
  • 勃林格殷格翰国际有限公司
  • Ceva
  • Elanco
  • HIPRA
  • 默克公司Inc.
  • NEOGEN Corporation
  • Virbac
  • Zoetis Inc.


North America Veterinary Vaccines Strategic Insights

Strategic insights for North America Veterinary Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-veterinary-vaccines-market-strategic-framework.webp
Get more information on this report

North America Veterinary Vaccines Report Scope

Report Attribute Details
Market size in 2021 US$ 3,721.85 Million
Market Size by 2028 US$ 5,884.41 Million
Global CAGR (2021 - 2028) 6.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 疫苗类型
  • 牲畜疫苗
  • 伴侣动物疫苗
By 技术
  • 减毒活疫苗
  • 灭活疫苗
  • 类毒素疫苗
  • 重组疫苗
  • 结合疫苗
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • BIOVAC
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • HIPRA
  • Merck & Co., Inc.
  • NEOGEN Corporation
  • Virbac
  • Zoetis Inc.
  • Get more information on this report

    North America Veterinary Vaccines Regional Insights

    The regional scope of North America Veterinary Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-veterinary-vaccines-market-geography.webp
    Get more information on this report

    The List of Companies - North America Veterinary Vaccines Market

    1. BIOVAC
    2. Boehringer Ingelheim International GmbH
    3. Ceva
    4. Elanco
    5. HIPRA
    6. Merck & Co., Inc.  
    7. NEOGEN Corporation
    8. Virbac
    9. Zoetis Inc.
    Frequently Asked Questions
    How big is the North America Veterinary Vaccines Market?

    The North America Veterinary Vaccines Market is valued at US$ 3,721.85 Million in 2021, it is projected to reach US$ 5,884.41 Million by 2028.

    What is the CAGR for North America Veterinary Vaccines Market by (2021 - 2028)?

    As per our report North America Veterinary Vaccines Market, the market size is valued at US$ 3,721.85 Million in 2021, projecting it to reach US$ 5,884.41 Million by 2028. This translates to a CAGR of approximately 6.8% during the forecast period.

    What segments are covered in this report?

    The North America Veterinary Vaccines Market report typically cover these key segments-

  • 疫苗类型 (牲畜疫苗, 伴侣动物疫苗)
  • 技术 (减毒活疫苗, 灭活疫苗, 类毒素疫苗, 重组疫苗, 结合疫苗)
  • What is the historic period, base year, and forecast period taken for North America Veterinary Vaccines Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Veterinary Vaccines Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in North America Veterinary Vaccines Market?

    The North America Veterinary Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • BIOVAC
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • HIPRA
  • Merck & Co., Inc.
  • NEOGEN Corporation
  • Virbac
  • Zoetis Inc.
  • Who should buy this report?

    The North America Veterinary Vaccines Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Veterinary Vaccines Market value chain can benefit from the information contained in a comprehensive market report.